Kaempferol 3‐O‐gentiobioside, an ALK5 inhibitor, affects the proliferation, migration, and invasion of tumor cells via blockade of the TGF‐β/ALK5/Smad signaling pathway
- 12 September 2021
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 35 (11) , 6310-6323
Abstract
Overactivation of TGF‐β/ALK5/Smad signaling pathway has been observed in the advanced stage of various human malignancies. As a key component of TGF‐β/ALK5/Smad signaling pathway transduction, TGF‐β type I receptor (also known as ALK5) has emerged as a promising therapeutic target for cancer treatment. In this study, to discover a novel ALK5 inhibitor, a commercial natural products library was screened using docking‐based virtual screening, followed by luciferase reporter assay. A flavonoid glycoside kaempferol 3‐O‐gentiobioside (KPF 3‐O‐G) was identified as a potent ALK5 inhibitor through directly bound to the ATP‐site of ALK5, resulting in the inhibitory effects on phosphorylation and translocation of Smad2 and expression of Smad4. Additionally, we found that KPF 3‐O‐G reduced cell proliferation and inhibited TGF‐β‐induced cell migration and invasion. Moreover, western blotting and immunofluorescent analysis showed that KPF 3‐O‐G significantly reversed the TGF‐β‐induced EMT biomarkers, including upregulation of E‐cadherin and downregulation of N‐cadherin, vimentin, and snail. In vivo study showed that KPF 3‐O‐G administration reduced tumor growth in human ovarian cancer xenograft mouse model, without obvious toxic effect. This study provided novel insight into the anticancer effects of KPF‐3‐O‐G and indicated that KPF‐3‐O‐G might be developed as potential therapeutics for cancer treatment after further validation.Keywords
Funding Information
- National Natural Science Foundation of China (81972040)
- Natural Science Foundation of Anhui Province (2008085QH396)
This publication has 42 references indexed in Scilit:
- Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stressEndocrine, 2018
- Medicinal plants used in the traditional management of diabetes and its sequelae in Central America: A reviewJournal of Ethnopharmacology, 2016
- Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathwayMolecular and Cellular Biochemistry, 2016
- Activin receptor‐like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytesEMBO Molecular Medicine, 2013
- Antidiabetic components ofCassia alataleaves: Identification through α-glucosidase inhibition studiesPharmaceutical Biology, 2012
- Blockade of TGF-β Signaling by the TGFβR-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in GlioblastomaCancer Research, 2011
- Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term TβRI/II Kinase Inhibition with LY2109761Cancer Research, 2011
- VEGF and inhibitors of TGFβ type-I receptor kinase synergistically promote blood-vessel formation by inducing α5-integrin expressionJournal of Cell Science, 2009
- SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7Molecular Pharmacology, 2004
- Antiinflammatory Activity of Heat-treated Cassia alata Leaf Extract and Its Flavonoid GlycosideYAKUGAKU ZASSHI, 2003